Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
04/30/1992 | WO1992007085A1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES |
04/30/1992 | WO1992007076A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
04/30/1992 | WO1992007075A1 Preparation of chimaeric antibodies using the recombinant pcr strategy |
04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
04/30/1992 | WO1992007063A2 A culture device having a detachable cell or tissue growth surface |
04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
04/30/1992 | WO1992006711A1 Blood coagulation protein antagonists and uses therefor |
04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
04/30/1992 | CA2094372A1 Blood coagulation protein antagonists and uses therefor |
04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
04/30/1992 | CA2054302A1 Monoclonal antibody-containing agent |
04/30/1992 | CA2054149A1 Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals |
04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
04/29/1992 | EP0482077A1 Method for producing novel polyester biopolymers |
04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
04/29/1992 | EP0482053A1 Dna constructs, cells and plants derived therefrom |
04/29/1992 | EP0482018A1 Toxin uses |
04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
04/28/1992 | US5108926 Apparatus for the precise positioning of cells |
04/28/1992 | US5108923 Decapeptides |
04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
04/28/1992 | US5108760 Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
04/28/1992 | US5108704 Microfiltration apparatus with radially spaced nozzles |
04/28/1992 | CA1299509C Serum-free medium useful for cultivating human monoclonal antibody-producing human/human hybridoma |
04/28/1992 | CA1299508C Human pancreatic elastase i |
04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
04/23/1992 | DE4033120A1 Genomic DNA fragment encoding antibody variable region prodn. - by attaching primers to hybridoma DNA then subjecting to polymerase chain reaction, for constructing genes encoding chimeric antibodies |
04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
04/22/1992 | EP0481791A2 Culture medium for CHO-cells and adapted CHO-cells |
04/22/1992 | EP0481790A2 Antibody production |
04/22/1992 | EP0481502A2 Process for the production of chimaeric antibodies |
04/22/1992 | EP0481089A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
04/22/1992 | EP0480971A1 A method for introducing molecules, particularly genetic material, into plant cells |
04/22/1992 | EP0472599A4 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |
04/22/1992 | EP0402449A4 Apparatus and process for culturing animal cells |
04/22/1992 | EP0245291B1 Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
04/22/1992 | EP0190362B1 Process for treating cells |
04/22/1992 | CN1060499A Human zona pellucida protein zp3 |
04/22/1992 | CN1016357B Simple ginseng-cell culturing method |
04/22/1992 | CN1016315B Process for preparing hepatitis b antigenic compositions |
04/21/1992 | US5107066 Using root cells of solanaceae |
04/21/1992 | US5106954 Erythropoietin (epo) peptides |
04/21/1992 | US5106747 Reduction in waste products and concomitant synthesis of amino acids |
04/21/1992 | US5106746 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
04/21/1992 | US5106743 Aqueous solution gelled with crosslinked polymer |
04/21/1992 | US5106627 For controlled delivery of encapsulated neurotransmitter to brain; growth factor source |
04/21/1992 | CA1299120C Stable dna constructs for expression of alpha-1-antitrypsin |
04/16/1992 | WO1992006194A1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
04/16/1992 | WO1992006193A1 Antibodies directed against cd3 |
04/16/1992 | WO1992006179A1 Biomaterial based on collagen and its applications |
04/16/1992 | WO1992006106A1 A plant protein useful for treating tumors and hiv infection |
04/16/1992 | WO1992005794A1 Method for producing th-independent cytotoxic t lymphocytes |
04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
04/16/1992 | WO1991018618A3 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
04/16/1992 | CA2093800A1 Plant protein useful for treating tumors and hiv infection |
04/16/1992 | CA2092548A1 Method for producing th-independent cytotoxic t lymphocytes |
04/15/1992 | EP0480762A2 Novel bacillus thuringiensis isolates active against dipteran pests |
04/15/1992 | EP0480730A2 Method and composition for increasing sterol accumulation in higher plants |
04/15/1992 | EP0480525A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
04/15/1992 | EP0480440A1 Monoclonal antibody against melanoma |
04/15/1992 | EP0480245A1 Method of culturing animal cells |
04/15/1992 | EP0480236A2 Resistance gene |
04/15/1992 | EP0480024A1 Plant thioesterases |
04/15/1992 | EP0479948A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
04/15/1992 | EP0479922A1 Monoclonal antibodies to c-reactive protein |
04/15/1992 | EP0479870A1 A mutated subtilisin protease |
04/15/1992 | EP0479866A1 Pestivirus nucleotide sequences and polypeptides |
04/15/1992 | EP0479834A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
04/15/1992 | EP0460101A4 Immobilized cytokines |
04/14/1992 | US5104853 Polypeptides |
04/14/1992 | US5104652 Compositions and method for treatment of cancer using monoclonal antibody against GD3 ganglioside together with IL-2 |
04/14/1992 | US5103821 Method of providing a biological pacemaker |
04/13/1992 | WO1992007271A1 Mouse monoclonal antibodies |
04/13/1992 | WO1992007081A2 A monoclonal antibody |
04/12/1992 | WO1992007269A1 Diagnostic method |
04/12/1992 | CA2069424A1 Diagnostic method |
04/08/1992 | EP0479721A2 Monoclonal antibodies directed against complexes formed by thrombin and thrombin inhibitors |
04/08/1992 | EP0479459A2 Production of quercetin glucuronide and cultured cells containing the same |
04/08/1992 | EP0479454A1 HIV-neutralizing rat monoclonal antibodies against PB-1 |
04/08/1992 | EP0479359A1 Transgenic plants having a modified carbohydrate content |
04/08/1992 | EP0479180A2 Virus resistant plants, method for their production |
04/08/1992 | EP0478696A1 Efficient method for identifiable expression of non-selectable genes. |
04/08/1992 | EP0478665A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
04/08/1992 | EP0478556A1 Characterization of a replication competent human immunodeficiency type 2 proviral clone |
04/08/1992 | EP0472659A4 T-lymphotropic retrovirus monoclonal antibodies |
04/08/1992 | CN1060112A Human c3b/c4b receptor (cr1) |